In 2023, the external defibrillation equipment market will continue to maintain steady growth, the technology and service level will be further improved, and the market competition will become more intense, and the brand will become the key to market competition. According to MDcloud statistics, in October 2023, a total of 313 bid-winning data for external defibrillation equipment were collected, involving 206 purchasing units and 19 brands.
Winning bids of external defibrillation equipment brands in October 2023 (TOP10), data**: MDCLOUD (medical device data cloud).
According to statistics, in October 2023, the TOP10 external defibrillation equipment brand list was announced, and in terms of the proportion of sales amount, domestic AEDs accounted for most of the market share, of which Mindray Medical accounted for 56With a market share of 21%, it ranks first with 14With a market share of 43%, Komen Medical ranks second with 8The market share of 72% ranked third, followed by Nippon Optoelectronics, Zall Zol, Philips, Yunshu Medical, Yuyue, and Lexicon.
October 2023 external defibrillation equipment brand and model winning status (TOP10) data**: MDCLOUD (medical equipment data cloud).
In terms of models, in October 2023, Mindray's external defibrillation device with the model of Beneheart C2 ranked first, accounting for 2452%；In second place is the i5 of Security Medical, with a total of 1442%；Japan Optoelectronics ranked third, with a model of TEC-5602, and the total number of winning bids accounted for 736%。
The continuous breakthroughs of domestic manufacturers in the field of AED have contributed to the healthy development of the domestic market. Before the emergence of domestic AED, the domestic market was occupied by foreign brands such as Philips, Zall and Japan Optoelectronics, and the unit price of the equipment was about 490,000 yuan, and the high selling price also hindered the popularization of AED to some extent.
In 2013, Mindray Medical developed China's first domestic AED and put it on the market, announcing a breakthrough for domestic brands in the field of AEDs. With the growth of the AED market, domestic enterprises such as Mindray, Yuyue, Jiuxin, Vivvis, Komen, and Ruixin Kangda have begun to make efforts, increase investment and R&D efforts, and gradually break the import monopoly and achieve domestic substitution.
1. Mindray Medical
Mindray is the first manufacturer in China to independently produce AEDs, and has many years of experience in defibrillation technology. The company has been committed to popularizing first aid knowledge to the public, and has improved public first aid skills by donating AED equipment and organizing first aid training. As the seed business that the company has invested heavily in, AED currently accounts for a small proportion of the company's revenue. The cost of equipment mainly includes first-class discharge module, main control module, mechanical components and consumables, etc., which are mainly self-made.
Launched in 2019, Mindray's Beneheart C series AEDs not only follow the previous innovative designs of large screens and the Internet of Things, but also further incorporate a number of patented innovative technologies such as Resqn**i and Qshock, making Mindray's AEDs far ahead in the domestic market.
As of September 30, 2023, Mindray's AED devices have successfully treated a total of 200 patients with cardiac arrest in public places in China. Throughout the third quarter, the company donated 225 AED equipment to partners, directly and indirectly driving 33750,000 people participated in first aid training.
2. Security medical care
Founded in 2001, Baoan Medical is a national high-tech enterprise specializing in comprehensive solutions for emergency and life support. The main products include: emergency transport ventilators, cardiopulmonary resuscitation machines, AEDs, defibrillators, electric sputum aspirators, neonatal ventilators, first aid training models, etc. Due to its excellent product quality, comparable to the international first-class level, a number of products and equipment have a high market share and good reputation in the country and even the world.
At the CMEF site this autumn, security medical AI products and solutions made a brilliant debut, the world premiere - AI intelligent first aid robot dog, security medical intelligent first aid robot dog shows its powerful functions and application scenarios, the arm is flexible and lightweight, can be rotated and adjusted at will, and the AED on the back can easily pass through the crowded rescue corridor, deliver the first aid materials and equipment to the rescue site in the first time, and provide life support services for patients.
3. Komen Medical
As the world's most abundant medical equipment manufacturer in the field of life support, it has launched nearly 200 products, including monitors, ventilators, AEDs, anesthesia machines, infusion care, electrocardiogram machines, defibrillation, surgical lights, operating tables, pendant suspension bridges, neonatal thermal insulation and nursery equipment, etc.
Komen Medical launched the external defibrillator monitor series in 2021, becoming the second manufacturer in China to independently develop and produce medical defibrillation, and successfully launched the F1 F2 series AED external defibrillator in 2022 with mature external defibrillation technology.
F1 F2 series AED external defibrillator adopts two-way exponential truncation wave, the maximum defibrillation energy can reach 360J, and the rescue success rate is higherThe impedance value ranges from 20 to 300, and it is suitable for more patient typesIt can support 360 times of 200J energy defibrillation, or 210 times of 360J energy defibrillation, and the number of battery discharges is the highest in the industryUsing the technology of heart rhythm analysis and charging synchronization, it only takes 7 seconds from boot to charging ready, saving rescue time and greatly improving the success rate of rescue.
4. Japan Optoelectronics
Founded in 1951, Nippon Optoelectronics Industry Co., Ltd. is a world-renowned R&D and manufacturing manufacturer of medical equipment, covering many fields such as electrocardiogram, monitoring, neuroelectrophysiology, first aid, clinical laboratory, laboratory equipment, clinical information system and home health care.
From 1990 to 2008, Nippon Optoelectronics has successively set up three branches in China: Shanghai Optoelectronics Medical Electronic Instruments (Shanghai) and Nihong Optoelectronics (Shanghai) On July 1, 2012, in order to further expand the Chinese market and provide users with better products and services, Nippon Optoelectronics integrated the resources of the three companies and established a new Shanghai Optoelectronics Medical Electronic Instruments
In August 2019, Shanghai Optoelectronics launched the AED-3100, which is 40% smaller in size and 15% lighter than the 2150K series, and the electrodes are colored, which can efficiently guide rescuers to paste the electrodes into the correct position.
5. Jiuxin Medical
Jiuxin Medical is a professional provider of pre-hospital emergency products and solutions in the cardiovascular field integrating R&D, production, sales and service, and is also the first national enterprise in China to obtain the AED registration certificate for Class III medical devices.
Jiuxin AED has been installed nearly 40,000 units across the country, serving the military, fire protection, public security, transportation, schools, communities, pension institutions, medical institutions, scientific research institutes, large enterprises, industrial parks, large-scale events and other customer groups, and has been exported to Europe and Southeast Asia, highly praised by overseas customers. So far, Jiuxin AED has successfully saved the lives of dozens of cardiac arrest patients.
On July 26, Jiuxin Medical announced that its product IAED-M1 was officially approved by the National Medical Products Administration and obtained the NMPA "Class III Medical Device Registration Certificate". This means that the official launch of the "Family First Aid Treasure" AED will accelerate the implementation of AED in the family first aid market and provide safe and efficient first aid protection for more families.
6. Zall zoll
Founded in 1980 and headquartered in Massachusetts, Zall has a comprehensive line of technologies that include defibrillation and monitoring, circulatory and CPR feedback, data management, fluid resuscitation, and **type body temperature control, helping clinicians, EMS and fire professionals, as well as lay patients**.
Zall provides a variety of clinically advanced defibrillators and AEDs (automated external defibrillators) to help improve the survival rate of cardiac arrest patients, and is the first company in the world to obtain pre-market approval for all defibrillation products.
7. Philips
For more than 50 years, Philips has been researching cardiac defibrillation technology and related algorithms, and has been working hard to translate innovations into cutting-edge technologies and novel designs. As a pioneer in the cardiac emergency market, Philips is committed to helping people around the world survive sudden cardiac arrest.
Philips' new generation of external defibrillator was unveiled at the 6th CIIE, the world premiere, focusing on the industry's attention. This HeartStart Intrepid external defibrillator was the first to be approved for marketing in China this year, and the time to submit an application and be approved is the first in the world. While achieving localization, it can also better serve the Chinese market.
8. Yunshu Medical
Founded on July 1, 2020, Yunshu Medical Technology Co., Ltd. is a company focusing on the R&D and production of medical equipment, and its products cover many fields such as external defibrillators and health management equipment.
9. Fish jump
In 2017, Yuyue Medical introduced the AED brand Promec Primedic, began to lay out the AED track, and launched the biphasic wave automatic external defibrillation series M600 under continuous R&D and innovation. As domestic brands continue to break through technical barriers, Yuyue Medical's AED has recently been approved for the "Medical Device Registration Certificate" in China, which can be turned on in only 1 second, and the battery life is as long as 65 years, and has been put into use in subways, stations, universities and commercial centers.
In April this year, the semi-automatic external defibrillator product of Pumeikang (Jiangsu) Medical Technology, a wholly-owned subsidiary of Yuyue Medical, was approved for marketing. It is understood that the product is registered as a Class III medical device, and semi-automatic external defibrillation** can be performed for suspected cardiac arrest patients who are unresponsive, breathless and have no normal pulse to terminate their tachycardia and ventricular fibrillation symptoms.
10. Lekmei
Lechem is an innovative and intelligent medical device manufacturing brand focusing on AED emergency scenarios, and is committed to building professional first-aid product solutions around China's first-aid scenarios with effective rescue as the core.
As a medical enterprise deeply engaged in the field of first aid, Lechem has been focusing on building an emergency security system for partners from all walks of life, and its flagship AED products have been deployed and installed in more than 150,000 units across the country, and at the same time provide complete AED first aid solutions, including site selection and installation, professional and systematic AED training, equipment and maintenance of first aid equipment, etc., which can effectively improve the response speed and success rate of emergency rescue, and promote the construction of public emergency system.
Statistics from China's National Center for Cardiovascular Diseases show that there are as many as 550,000 sudden cardiac deaths in China every year, with an average of 1,500 people dying of cardiac arrest every day, and one person suddenly falls to the ground every minute because of cardiac arrest, and 87% of these accidents occur outside the hospital.
Studies have shown that within 1 minute after the occurrence of sudden death, CPR should be implemented immediately and AED should be used to carry out first aid, and the success rate of rescue can reach 90%;For every 1 minute of delay, the success rate decreases by 7% to 10%, and cardiac arrest exceeds 4 minutes, and permanent damage to brain tissue occurs. Therefore, these 4 minutes are also called the "**4 minutes" of first aid.
As a medical device that can diagnose specific arrhythmias and give electric shock defibrillation, AED is a medical device used by non-professionals to rescue cardiac arrest patients, and is currently recognized as a "life-saving device" for rescuing cardiac arrest patients.
It's just that for a long time, the allocation rate of AEDs in China has been too low, with less than 2 AEDs per 100,000 population, and the data of the "Expert Consensus on China's AED Layout and Delivery" in 2020 shows that the United States and Japan have an average of 700 and 276 AEDs per 100,000 people, and we are far from each other.
With the increase of investment, the boost of various policies, the awakening of public health awareness, the popularization of first aid knowledge, and the breakthrough of domestic AED equipment from scratch, the domestic AED industry has developed rapidly.
As early as 2010, Hainan Province issued the Regulations of the Red Cross Society of Hainan Province, which became the first batch of regulations in China to include AEDIn 2015, the Shanghai Red Cross Society launched a pilot program for AED, deploying AEDs in public places such as airports and subwaysIn 2017, Shenzhen** also included the "Public Electric Defibrillation Plan" into the key projects of people's livelihood;In 2019, the General Office of *** announced the "Healthy China Action (2019 2030)", announcing that AEDs will be equipped in schools, institutions, enterprises and institutions, airports, stations, port passenger terminals, large shopping malls and other crowded places.
By the end of 2021, the National Health Commission formulated the "Guidelines for the Configuration of Automated External Defibrillators in Public Places (Trial)", and then documents on the configuration of AEDs were successively issued across the country, and the domestic market began to expand.
In 2022 alone, more than 20 provinces and cities announced AED allocation plans, including Shenzhen, Hainan, Fujian, Jiangxi, Sichuan, etc. According to the standard of 100 200 units and 100,000 people of the National Health Commission, China's AED configuration can reach a maximum of about 3 million units, and the market size is nearly 60 billion. If the penetration rate of developed countries such as the United States and Japan is reached, the market will exceed the 100 billion mark.
Article**: Medical Device Innovation Network, Refer to Zhongcheng Medical Equipment.